Scarton Lisa, Oh Sungho, Sylvera Ashley, Lamonge Ralph, Yao Yingwei, Chochinov Harvey, Fitchett George, Handzo George, Emanuel Linda, Wilkie Diana
1 University of Florida College of Nursing, Gainesville, FL, USA.
2 Department of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada.
Am J Hosp Palliat Care. 2018 Nov;35(11):1417-1420. doi: 10.1177/1049909118777987. Epub 2018 May 24.
Feasibility of dignity therapy (DT) is well established in palliative care. Evidence of its efficacy, however, has been inconsistent and may stem from DT's primary effects differing from the outcomes measured in previous studies. We proposed that DT effects were in the spiritual domain and created a new outcome measure, Dignity Impact Scale (DIS), from items previously used in a large randomized controlled trial (RCT).
The purpose of this secondary analysis study was to examine properties of a new measure of dignity impact.
Using the DIS, we conducted reanalysis of posttest data from a large 3-arm, multi-site RCT study.
SETTING/PARTICIPANTS: Participants were receiving hospice/palliative care (n = 326, 50.6% female, mean age = 65.1 years, 89.3% white, all with a terminal illness with 6 months or less life expectancy). They had been randomized to standard palliative care (n = 111), client-centered care (n = 107), or DT (n = 108).
The 7-item DIS was derived from selected items in a posttest DT Patient Feedback Questionnaire. The DIS had strong internal consistency (α = 0.85).
The DT group mean DIS score (21.4 ± 5.0) was significantly higher than the usual care group mean score (17.7 ± 5.5; t = 5.2, df = 216, P < .001) and a client-centered intervention group mean score (17.9 ± 4.9; t = 5.2, df = 213, P < .001).
We found that, compared to both other groups, patients who received DT reported significantly higher DIS ratings, which is consistent with the DT focus on meaning-making, preparation for death, and life completion tasks. We propose that the DIS be used as the primary outcome measure in evaluating the effects of DT.
尊严疗法(DT)在姑息治疗中的可行性已得到充分证实。然而,其疗效证据并不一致,可能源于DT的主要效果与先前研究中所测量的结果不同。我们认为DT的效果体现在精神领域,并从先前一项大型随机对照试验(RCT)中使用的项目创建了一个新的结果测量指标,即尊严影响量表(DIS)。
这项二次分析研究的目的是检验一种新的尊严影响测量指标的特性。
我们使用DIS对一项大型三臂、多中心RCT研究的后测数据进行了重新分析。
设置/参与者:参与者正在接受临终关怀/姑息治疗(n = 326,女性占50.6%,平均年龄 = 65.1岁,89.3%为白人,均患有预期寿命为6个月或更短的晚期疾病)。他们被随机分为标准姑息治疗组(n = 111)、以患者为中心的治疗组(n = 107)或DT组(n = 108)。
7项DIS源自后测DT患者反馈问卷中的选定项目。DIS具有很强的内部一致性(α = 0.85)。
DT组的DIS平均得分(21.4 ± 5.0)显著高于常规护理组的平均得分(17.7 ± 5.5;t = 5.2,df = 216,P <.001)和以患者为中心的干预组的平均得分(17.9 ± 4.9;t = 5.2,df = 213,P <.001)。
我们发现,与其他两组相比,接受DT的患者报告的DIS评分显著更高,这与DT关注意义构建、死亡准备和生命完成任务一致。我们建议将DIS用作评估DT效果的主要结果测量指标。